Overview
Organized by DIA and CoRE
In the current landscape of rapid advances in medical sciences and technology, many opportunities abound for improving the quality and delivery of healthcare. New technology, systems and concepts are constantly explored to bring better health outcomes for patients.
Beyond innovations in health products, IT continue to advance the changes with increasing utility of data sciences and Artificial Intelligence in transforming healthcare management. Given the complex interactions among the stakeholders, it is vital to be well-informed of the significant progresses and collaboration with relevant stakeholders to fully harness the value of this exciting evolution in healthcare.
Download the Preliminary Agenda to Explore Discussions on:- eLabeling as a Tool for Enhancing Patient Care
- Disruptive Technology - Innovating Clinical Trials
- Personalized Healthcare - Pivotal Role for Next Generation Sequencing
- 3D Printing for Personalized Medical Devices
- Relating Medical Device and Pharmaceutical Regulations
- Inclusivity - The Importance of the Patient Perspective
Who should attend?
- Industry professionals involved in Pharmaceuticals & Medical Technolgies involved in Research & Development, Regulatory Affairs and Market Access and Medical Affairs
- Regulators and personnel from Health Authorities and Ministries
- Academia and Researchers
Program Committee
-
Dorothee Grimald, PharmD • Director, Global Regulatory Policy

MSD Singapore, Singapore -
James Leong, PhD, MPharm • Head of Pharmaceutical Regulatory Science Programme

Duke NUS, Singapore -
Audrey Ooi Joo Ann • Acting Head of Business Development

Clinical Research Malaysia, Malaysia -
Finny Liu, MSc, RPh • APAC Regional Regulatory Policy Lead

Roche Singapore Pte Ltd, Singapore -
Jack Wong • Associate Vice President, Regulatory Affairs, APAC-MEA

Allergan Singapore Pte. Ltd., Singapore -
Mei Ding • JAPAC Regional Lead, Policy & Intelligence

Abbvie Pte. Ltd., Singapore -
Thean Soo Lo • Director, Asia Pacific Regulatory Policy Lead, Global Regulatory Affairs

Janssen-Cilag J&J Asia Pacific, Singapore -
Yasha Huang • Asia Pacific Medical Technology Association (APACMed)

Director - Regulatory Affairs, China -
Shun Jin, MBA • Head, Regulatory Affairs, APMA

Sandoz Asia Pacific Pharmaceutical Pte., Ltd., Singapore -
Fredrik Nyberg • Managing Director, Asia Pacific

MedTech Innovator, Singapore -
Jing Ping Yeo, PhD • Director, Research Integrity, Compliance and Ethics

Singhealth, Singapore -
Kum Cheun Wong, PharmD • Head Asia Pacific Regulatory & Development Policy

Novartis Asia Pacific Pharmaceuticals Pte. Ltd., Singapore -
Vicky (Fengyun) Han • Senior Director, Asia Pacific Regulatory Policy Group Lead, Asia Pacific

Johnson & Johnson Pte. Ltd., Singapore
